Literature DB >> 23002284

Immunohistochemistry in the era of personalised medicine.

Clare Margaret McCourt1, David Boyle, Jacqueline James, Manuel Salto-Tellez.   

Abstract

BACKGROUND: Immunohistochemistry (IHC) plays a central role in the histopathological classification of diseases, including cancer. More recently, the importance of immunohistochemical staining is increasing. IHC usage in diagnostics is invaluable; however, the genetic and therapeutic significance of biomarker immunostaining has become equally relevant. CONTENT: In this article, we would like to analyse the three distinct roles of IHC and review their individual impacts on modern diagnostic pathology: (1) diagnostic IHC; (2) genetic IHC and (3) therapeutic IHC.
SUMMARY: Thus, we will characterise the different analytical processes that are required in the three approaches to IHC usage stated above, as well as the clinical significance and overall importance in patient management. This will allow us to hypothesise on the most appropriate laboratory environment and detection methods for the future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23002284     DOI: 10.1136/jclinpath-2012-201140

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  Automated Identification and Quantification of Signals in Multichannel Immunofluorescence Images: The SignalFinder-IF Platform.

Authors:  Daniel Barnett; Johnathan Hall; Brian Haab
Journal:  Am J Pathol       Date:  2019-04-23       Impact factor: 4.307

2.  Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

Authors:  Julian C Schink; Julia R Trosman; Christine B Weldon; Kalliopi P Siziopikou; Gregory J Tsongalis; Alfred W Rademaker; Jyoti D Patel; Al B Benson; Edith A Perez; William J Gradishar
Journal:  J Natl Cancer Inst       Date:  2014-09-12       Impact factor: 13.506

3.  Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer.

Authors:  Peter P Truran; Sarah J Johnson; Richard D Bliss; Thomas W J Lennard; Sebastian R Aspinall
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

4.  Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.

Authors:  Garrett M Frampton; Alex Fichtenholtz; Geoff A Otto; Kai Wang; Sean R Downing; Jie He; Michael Schnall-Levin; Jared White; Eric M Sanford; Peter An; James Sun; Frank Juhn; Kristina Brennan; Kiel Iwanik; Ashley Maillet; Jamie Buell; Emily White; Mandy Zhao; Sohail Balasubramanian; Selmira Terzic; Tina Richards; Vera Banning; Lazaro Garcia; Kristen Mahoney; Zac Zwirko; Amy Donahue; Himisha Beltran; Juan Miguel Mosquera; Mark A Rubin; Snjezana Dogan; Cyrus V Hedvat; Michael F Berger; Lajos Pusztai; Matthias Lechner; Chris Boshoff; Mirna Jarosz; Christine Vietz; Alex Parker; Vincent A Miller; Jeffrey S Ross; John Curran; Maureen T Cronin; Philip J Stephens; Doron Lipson; Roman Yelensky
Journal:  Nat Biotechnol       Date:  2013-10-20       Impact factor: 54.908

Review 5.  Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy.

Authors:  C G Drake; P Sharma; W Gerritsen
Journal:  Oncogene       Date:  2013-11-25       Impact factor: 9.867

6.  Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients.

Authors:  Pingzhou Yang; Milind Javle; Fei Pang; Wei Zhao; Reham Abdel-Wahab; Xiaofeng Chen; Funda Meric-Bernstam; Huanwei Chen; Mitesh J Borad; Yu Liu; Chuntao Zou; Shuo Mu; Yutong Xing; Kai Wang; Chuang Peng; Xu Che
Journal:  Hepatobiliary Surg Nutr       Date:  2019-12       Impact factor: 7.293

Review 7.  Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer.

Authors:  Ryan A Hutchinson; Richard A Adams; Darragh G McArt; Manuel Salto-Tellez; Bharat Jasani; Peter W Hamilton
Journal:  J Transl Med       Date:  2015-07-07       Impact factor: 5.531

Review 8.  Not All Next Generation Sequencing Diagnostics are Created Equal: Understanding the Nuances of Solid Tumor Assay Design for Somatic Mutation Detection.

Authors:  Phillip N Gray; Charles L M Dunlop; Aaron M Elliott
Journal:  Cancers (Basel)       Date:  2015-07-17       Impact factor: 6.639

9.  Probing fibronectin-antibody interactions using AFM force spectroscopy and lateral force microscopy.

Authors:  Andrzej J Kulik; Małgorzata Lekka; Kyumin Lee; Grazyna Pyka-Fościak; Wieslaw Nowak
Journal:  Beilstein J Nanotechnol       Date:  2015-05-15       Impact factor: 3.649

10.  Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methods.

Authors:  Louise Dubois; Karl Andersson; Anna Asplund; Hanna Björkelund
Journal:  BMC Res Notes       Date:  2013-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.